SEC Filing Summary for Jon P. Stonehouse - Biocryst Pharmaceuticals Inc.

This filing details a transaction by Jon P. Stonehouse, a director at Biocryst Pharmaceuticals Inc. On August 31, 2026, Mr. Stonehouse acquired 644 shares of Common Stock at a price of $9.70 per share. These shares were issued in lieu of 50% of his quarterly cash Board Member retainer. Following this transaction, Mr. Stonehouse directly owns 1,340,419 shares. Additionally, he has indirect ownership of 40,000 shares held by his wife as co-trustee of the Caroline Stonehouse Irrevocable Trust, and another 40,000 shares held by his wife as co-trustee of the Samuel Stonehouse Irrevocable Trust.